ℹ️ Compiled from public regulatory records · Last regulator revision: May 27, 2026🚩 Report this page

Mifepristone

Progesterone Receptor Modulators

Sold as MIFISO · FEMYSO · MIFEGYMISO

CA Health CanadaGB MHRA

Drug class: Progesterone Receptor Modulators
Availability: See label
Routes: Buccal, Oral
Markets covered: 2
Products on record: 8

Overview

Mifepristone is an active pharmaceutical ingredient in the Progesterone Receptor Modulators group (G03XB). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.

Regulatory status by market

Market	Regulator	Products	Last revision
CA Canada	Health Canada	4	May 27, 2026
GB United Kingdom	MHRA	4	May 15, 2026

CACanada· Health Canada

4 products

Uses

CAOfficial regulatory label· revised July 11, 2025[1]

Mifiso (mifepristone tablet/misoprostol tablets) is indicated for:  medical termination of a developing intra-uterine pregnancy with a gestational age up to 63 days as measured from the first day of the Last Menstrual Period (LMP) in a presumed 28-day cycle.
Mifiso is not intended for routine use as a contraceptive. 1 Pediatrics Pediatrics (<15 years of age): There are insufficient data in patients less than 15 years old to establish efficacy and safety. Mifiso is not indicated in the prepubertal population.
Pediatrics (>15 and <18 years of age):
Compared to adults, patients less than 18 years of age reported vomiting and pain more frequently (see WARNINGS AND PRECAUTIONS, Special Populations, Pediatrics). 2 Geriatrics Geriatrics (>65 years of age): Mifiso is not indicated in post-menopausal women.

GBUnited Kingdom· MHRA

4 products

Uses

GBOfficial regulatory label· revised May 15, 2026[2]

1- Medical termination of developing intra-uterine pregnancy. 2). 2- Softening and dilatation of the cervix uteri prior to surgical termination of pregnancy during the first trimester. 3- Preparation for the action of prostaglandin analogues in the termination of pregnancy for medical reasons (beyond the first trimester).
4- Labour induction in fetal death in utero. In patients where prostaglandin or oxytocin cannot be used.

How to take

Drug interactions

Known interactions involving Mifepristone. Select one for details. This list is informational and not a complete interaction checker.

Abarelix Abiraterone Acalabrutinib Adenosine Albuterol Alfentanil Alfuzosin Amiodarone Amisulpride Amitriptyline Amoxapine Amprenavir Anagrelide Anisindione Apalutamide Apixaban Apomorphine Ardeparin Argatroban Arsenic Trioxide Artemether Asenapine Astemizole Atazanavir Atomoxetine Avanafil Avapritinib Axitinib Azithromycin Bedaquiline Benzhydrocodone Bepridil Betamethasone Betrixaban Bicalutamide Bivalirudin Boceprevir Bosutinib Brexpiprazole Brigatinib Budesonide Buprenorphine Butorphanol Cabozantinib Cangrelor Capmatinib Cariprazine Ceritinib Chloroquine Chlorpromazine Cilostazol Ciprofloxacin Cisapride Citalopram Clarithromycin Clofazimine Clomipramine Clopidogrel Clozapine Cobicistat Cobimetinib Colchicine Conivaptan Corticotropin Cosyntropin Crizotinib Cyclosporine Daclatasvir Dalteparin Danaparoid Darifenacin Dasatinib Daunorubicin Defibrotide Deflazacort Degarelix Delavirdine Desipramine Desirudin Deutetrabenazine Dexamethasone Dicumarol Dihydroergotamine Dinoprostone Disopyramide Docetaxel Dofetilide Dolasetron Doxepin Doxorubicin Dronedarone Droperidol Edoxaban Efavirenz Eletriptan Eliglustat Encorafenib Enoxaparin Entrectinib Enzalutamide Epirubicin Eplerenone Ergotamine Eribulin Erythromycin Escitalopram Everolimus Ezogabine Fentanyl Fingolimod Flecainide Flibanserin Fluconazole Fludrocortisone Flunisolide Fluoxetine Fluphenazine Flutamide Fluticasone Fondaparinux Fosamprenavir Foscarnet Fostemsavir Gatifloxacin Gemifloxacin Gilteritinib Glasdegib Goserelin Granisetron Grepafloxacin Guanfacine Halofantrine Haloperidol Halothane Heparin Histrelin Hydrocodone Hydrocortisone Hydroxychloroquine Hydroxyzine Ibutilide Idarubicin Idelalisib Iloperidone Imipramine Indinavir Inotuzumab Ozogamicin Irinotecan Isoproterenol Itraconazole Ivabradine Ivosidenib Ketoconazole Lapatinib Larotrectinib Lefamulin Lenvatinib Lepirudin Leuprolide Levofloxacin Lisdexamfetamine Lithium Carbonate Lofexidine Lomefloxacin Lomitapide Lonafarnib Lovastatin Lurasidone Macimorelin Maprotiline Mefloquine Mesoridazine Metaproterenol Methadone Methotrimeprazine Methylprednisolone Methysergide Midazolam Midostaurin Mirtazapine Moxifloxacin Naloxegol Nefazodone Nelfinavir Neratinib Nilotinib Nilutamide Nisoldipine Norfloxacin Nortriptyline Ofloxacin Oliceridine Ondansetron Osilodrostat Osimertinib Oxaliplatin Oxycodone Oxytocin Ozanimod Paliperidone Palonosetron Panobinostat Papaverine Pasireotide Pazopanib Pentamidine Perflutren Perphenazine Pimavanserin Pimozide Pitolisant Posaconazole Prasugrel Prednisolone Prednisone Primaquine Probucol Procainamide Prochlorperazine Promazine Promethazine Propafenone Propoxyphene Protriptyline Quetiapine Quinidine Quinine Ranolazine Relugolix Ribociclib Rilpivirine Ripretinib Risperidone Ritodrine Ritonavir Rivaroxaban Romidepsin Rucaparib Saquinavir Selpercatinib

Showing 240 of 539. Type above to find a specific drug.

Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.

Sources & citations

[1]Health Canada (DPD) · 02533553 · revised July 11, 2025
[2]MHRA (UK) · PL469730006 · revised May 15, 2026

Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.